United Therapeutics sues FDA over handling of Liquidia’s NDA
United has commenced litigation with the FDA to combat Liquidia’s Yutrepia encroaching on the market for its leading drug Tyvaso.
United has commenced litigation with the FDA to combat Liquidia’s Yutrepia encroaching on the market for its leading drug Tyvaso.
What's Your Reaction?
